U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Net Income	-3.31	-4.29	-3.38	-5.04	-2.16
Depreciation & Amortization	0.69	0.98	0.45	0.24	0.21
Share-Based Compensation	0.38	0.56	0.7	0.82	0
Other Operating Activities	1.93	1.7	1.75	2.76	2.56
Operating Cash Flow	-0.3	-1.06	-0.48	-1.21	0.6
Operating Cash Flow Growth	-	-	-	-	-51.07%
Capital Expenditures	0	0	0	-0.17	0
Acquisitions	0	0	0	0.17	0.31
Change in Investments	-	-	-	-0.15	-0.12
Other Investing Activities	-	-	-	0.32	0.12
Investing Cash Flow	0	0	0	0.17	0.31
Common Stock Issued	0.09	0.28	0	0.05	0
Other Financing Activities	0.19	0.8	0.5	-0.36	-0.54
Financing Cash Flow	0.27	1.08	0.5	-0.31	-0.54
Net Cash Flow	-0.03	0.02	0.02	-1.36	0.37
Free Cash Flow	-0.3	-1.06	-0.48	-1.38	0.6
Free Cash Flow Growth	-	-	-	-	-51.03%
Free Cash Flow Margin	-371.55%	-527.00%	-172.83%	-44.85%	8.99%
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	0.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.